Send feedback

SPAST p.Pro293=

c.879G>A · rs145264166 · VCV219840

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 14 submitters
gnomAD v4.1
Rare
low-frequency (popmax 1.47%, nfe)
Conditions
2
hereditary spastic paraplegia 4

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.67GERP -1.9, phastCons 0.94
Overall
CADD12.06PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.47% European (non-Finnish) · 17,234/1,174,802 alleles
Filtering AF 1.45% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.44%
Overall 1.25% 20,070/1,607,230 alleles · low-frequency exomes 18,683/1,455,134 · genomes 1,387/152,096 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 1.93% 52
European (non-Finnish)grpmax 1.47% 68
Remaining individualsnot grpmax-eligible 1.22% 82
Finnishnot grpmax-eligible 0.996% 100
Admixed American 0.77% 130
Amishnot grpmax-eligible 0.439% 228
Middle Eastern 0.248% 403
South Asian 0.246% 406
African / African-American 0.211% 474
East Asian 0.0179% 5,579

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPAST
Protein
p.Pro293=
Coding
c.879G>A
MANE Select
NM_014946
dbSNP
rs145264166
Type
single nucleotide variant
Location
chr2:32115710 (GRCh38)
Gene constraint
LOEUF 0.69 · pLI 0.11 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.03 · 7 PDB
Residue 293
the 'sufficient for microtubule severing' region; the 'required for interaction with microtubules and microtubule severing' region; the 'disordered' region; a UniProt-annotated variant site (in spg4); the 'required for interaction with rtn1' region
Full SPAST gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary spastic paraplegia

For Autosomal dominant spastic paraplegia type 4 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Portugal)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spast-p-pro293 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown